After a six-week period of controlled trials, the FDA approves a drug that appears safe and effective in the treatment of school-age boys with ADHD.

After a six-week period of controlled trials, the FDA approves a drug that appears safe and effective in the treatment of school-age boys with ADHD. Once it is approved, doctors are permitted to prescribe it for any patients who:

           a. match the subjects in the controlled study in regard to gender--in this example, males with a diagnosis of ADHD.

           b.match subjects in the controlled study in regard to age--in this example, school age boys and girls.

           c. match subjects in the controlled study in regard to ethnicity or cultural background--in this example, Americans.